Literature DB >> 22547262

Localization of a site of action for benzofuroindole-induced potentiation of BKCa channels.

Byoung-Cheol Lee1, Hyun-Ho Lim, Songmi Kim, Hyung-Seop Youn, Yuno Lee, Yong-Chul Kim, Soo Hyun Eom, Keun Woo Lee, Chul-Seung Park.   

Abstract

As previously reported, the activity of the large-conductance calcium (Ca(2+))-activated potassium (K(+)) (BK(Ca)) channel is strongly potentiated from the extracellular side of the cell membrane by certain benzofuroindole derivatives. Here, the mechanism of action of one of the most potent activators, 4-chloro-7-(trifluoromethyl)-10H-benzofuro[3,2-b]indole-1-carboxylic acid (CTBIC), is characterized. This compound, Compound 22 in the previous report (Chembiochem 6:1745-1748, 2005), potentiated the activity of the channel by shifting its conductance-voltage relationship toward the more negative direction. Cotreatment with CTBIC reduced the affinity of charybdotoxin, a peptide pore-blocker, whereas that of tetraethylammonium, a small pore-blocking quaternary ammonium, was not significantly altered. Guided by these results, scanning mutagenesis of the outer vestibule of the BK(Ca) channel was launched to uncover the molecular determinants that affect CTBIC binding. Alanine substitution of several amino acid residues in the turret region and the S6 helix of the channel decreased potentiation by CTBIC. Homology modeling and molecular dynamics simulation showed that some of these residues formed a CTBIC binding pocket between two adjacent α-subunits in the outer vestibule of the channel. Thus, it can be envisioned that benzofuroindole derivatives stabilize the open conformation of the channel by binding to the residues clustered across the extracellular part of the subunit interface. The present results indicate that the interface between different α-subunits of the BK(Ca) channel may play a critical role in the modulation of channel activity. Therefore, this interface represents a potential therapeutic target site for the regulation of K(+) channels.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22547262     DOI: 10.1124/mol.112.078097

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  3 in total

1.  Cerebrovascular dilation via selective targeting of the cholane steroid-recognition site in the BK channel β1-subunit by a novel nonsteroidal agent.

Authors:  Anna N Bukiya; Jacob E McMillan; Alexander L Fedinec; Shivaputra A Patil; Duane D Miller; Charles W Leffler; Abby L Parrill; Alex M Dopico
Journal:  Mol Pharmacol       Date:  2013-03-01       Impact factor: 4.436

2.  Calcium- and voltage-gated potassium (BK) channel activators in the 5β-cholanic acid-3α-ol analogue series with modifications in the lateral chain.

Authors:  Anna N Bukiya; Shivaputra A Patil; Wei Li; Duane D Miller; Alex M Dopico
Journal:  ChemMedChem       Date:  2012-09-04       Impact factor: 3.466

3.  Intracellular calcium-dependent regulation of the sperm-specific calcium-activated potassium channel, hSlo3, by the BKCa activator LDD175.

Authors:  Tharaka Darshana Wijerathne; Jihyun Kim; Dongki Yang; Kyu Pil Lee
Journal:  Korean J Physiol Pharmacol       Date:  2017-02-21       Impact factor: 2.016

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.